A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.

scientific article

A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1464-5491.2000.00258.X
P698PubMed publication ID10784225

P2093author name stringGale EA
P2860cites workInsulin lispro.Q41528865
The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.Q51570861
Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin.Q51574233
Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.Q52232111
Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.Q53974364
P433issue3
P921main subjecttype-1 diabetesQ124407
patientQ181600
regular insulinQ2893248
preproinsulinQ7240673
randomized controlled trialQ1436668
P304page(s)209-214
P577publication date2000-03-01
P1433published inDiabetic MedicineQ15758639
P1476titleA randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
P478volume17

Reverse relations

cites work (P2860)
Q35585217An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.
Q34404783Clinical pharmacokinetics and pharmacodynamics of insulin aspart
Q34511505Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)
Q44052260Controlled multicenter study on the effect of computer assistance in intensive insulin therapy of type 1 diabetics
Q43765254Conversion of fast insulin intensive therapy to lispro insulin in type I diabetes. Pharmacoeconomic analysis of cost-effectiveness
Q58448022Counter-regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double-blinded randomized cross-over study
Q35703026Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
Q53491062Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: assessment of improvements in treatment satisfaction with a new insulin analogue.
Q40573593Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes.
Q24656013Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis
Q34069247Efficacy of insulin lispro in improving glycemic control in gestational diabetes
Q37088908Insulin analogues: too much noise about small benefits
Q41762382Insulin glulisine in the management of diabetes
Q34982099Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus
Q36750094Insulin lispro: a review of its use in the management of diabetes mellitus
Q35183776Insulin lispro: a useful advance in insulin therapy
Q34906391Insulin therapy in Europe
Q34365284Insulins today and beyond
Q51567062Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy.
Q80625647Nice insulins, pity about the evidence
Q36506133Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control
Q44791689Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetes
Q51733821Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
Q36942084Randomized crossover study to examine the necessity of an injection-to-meal interval in patients with type 2 diabetes and human insulin
Q92232936Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes
Q47871150Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls
Q38159475Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention.
Q24246142Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
Q24246326Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
Q60921475Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
Q37167474Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review

Search more.